There were two NEPA patients and one APR/GRAN patient with serious TRAEs (NEPA: 1) atrial fibrillation and 2) chest pain/hypotension/decreased heart rate/nonresponsiveness (concomitant medication included amifostine); APR/GRAN: increased alanine aminotransferase). This evidence concerns the gene GPT and atrial fibrillation.